Hugh McMillan

Professor, Department of Pediatrics, University of Ottawa

Pediatric Neurologist and Neuromuscular specialist at the Children’s Hospital of Eastern Ontario

Email Hugh

Dr. McMillan is a Pediatric Neurologist with specialization in Clinical Neurophysiology and Neuromuscular medicine at the Children’s Hospital of Eastern Ontario. He is a Professor in the Department of Pediatrics, Faculty of Medicine at the University of Ottawa.  He holds a Clinical Research Chair (Level 2) at the University of Ottawa and is a Clinical Investigator at the CHEO Research Institute

He has been an author of over 125 publications in peer-review journals and was a co-editor of a Pediatric Electromyography textbook.  He is also a leader in clinical and translational research in pediatric neurology & neuromuscular medicine.

Dr. McMillan completed a Neuromuscular and Neurophysiology Fellowship at Boston Children’s Hospital, Harvard University and the Lahey Clinic, Tufts University; a Pediatric Neurology Residency at the Children’s Hospital of Eastern Ontario, University of Ottawa and a Pediatric Residency at McMaster Children’s Hospital, McMaster University.

Dr. Hugh McMillan profile picture.

Read more about Hugh

Academic web profile
ORCiD profile

Recent publications

Ahmadiharchegani, F, Tobin, RA, Degan, C, Naveed, A, Guglieri, M, Jiménez-Requena, A et al.. Circulating protein biomarkers identified in two independent clinical trial cohorts of glucocorticoid-naive Duchenne muscular dystrophy patients. Sci Rep. 2025.15 (1)39997 PMID:41238663

Proud, CM, Kichula, EA, Matesanz, SE, Kumar, A, Saito, K, Laverty, CG et al.. Onasemnogene abeparvovec gene therapy for treatment of patients with spinal muscular atrophy: Updated real-world practical considerations. J Neuromuscul Dis. 2025. 22143602251391258 PMID:41212681

Dussah, N, McKim, DA, Mah, JK, McMillan, HJ, Campbell, C, Bijelić, V et al.. Patterns of Adherence to Lung Volume Recruitment Therapy Amongst Individuals With Duchenne Muscular Dystrophy: A Secondary Analysis of the STEADFAST Randomized Controlled Trial. Pediatr Pulmonol. 2025.60 (10)e71357 PMID:41147267

Phung, K, Rauch, D, Jackowski, S, Scharke, M, Koujok, K, Matzinger, MA et al.. Automated bone age calculation is an independent predictor of vertebral fracture burden in Duchenne muscular dystrophy. Osteoporos Int. 2025.36 (11)2287-2297 PMID:41120763

Schiava, M, Dang, UJ, Wood, C, Wong, SC, Ward, LM, Lofra, RM et al.. Height, weight, and body mass index trajectories and their correlation with functional outcome assessments in boys with Duchenne muscular dystrophy. Dev Med Child Neurol. 2025. PMID:40887311

De Ford, C, Guridi, M, Chen, Y, Murphy, AP, Wood, C, McMillan, HJ et al.. Exploring the natural history of bone mineral density in Duchenne muscular dystrophy: a systematic literature review. Osteoporos Int. 2025.36 (11)2097-2113 PMID:40879743

Ippolito, C, Deguise, MO, Lochmüller, H, McMillan, HJ, McAdam, L. Bullying experiences of youth with neuromuscular disorders and their well-being: A survey study. J Neuromuscul Dis. 2025. 22143602251369279 PMID:40853190

Grant, A, Smith, IC, Lessard, LER, Osman, H, Lochmuller, H, McMillan, HJ et al.. Financial Toxicity and Its Determinants in Individuals Living With Inherited and Acquired Neuromuscular Disorders: The BIND Study. Neurology. 2025.105 (5)e213982 PMID:40834345

Eisenkölbl, A, Lochmüller, H, Carter, MT, Hamilton, LE, McMillan, HJ. Congenital-onset MLASA2 from a novel YARS2 variant: A literature review. J Neuromuscul Dis. 2025. 22143602251369227 PMID:40808490

Pace, A, Roda, W, Poon, C, McMillan, HJ, Oskoui, M, MacKenzie, A et al.. A cost-utility analysis of newborn screening for spinal muscular atrophy in Canada. Orphanet J Rare Dis. 2025.20 (1)428 PMID:40804727

See more on PubMed